Almost all of us hate to clean. But almost none of us are involved in the critical process of making preservative-free medications to be injected directly into your spinal tissue, providing an easy pathway to meningitis formation.
The FDA says that among the information its investigation have found so far are internal NECC compounding pharmacy reports showing that staffers there had documented dozens of cases of mold and bacteria growing in rooms that were supposed to be sterile and free of contamination. Injectable steroid medications from the NECC (New England Compounding Center) have been linked to the fungal meningitis outbreak that so far has killed 25 people and sickened 338 at last count. The count keeps going up every day.
Your Health is at Risk. Contact the Texas Drug Injury Lawyers at Denena & Points to Report Exposure to Contaminated Medication
The Texas Drug Injury Lawyers at Denena & Points have been following the progress of the troubling fungal meningitis outbreak throughout the United States. And we want to ensure that patients at risk from the contaminated medications report any symptoms of meningitis right away and get help immediately.
Fungal meningitis can be treated with courses of anti-fungal medications. Patients’ chances of surviving infection are higher the sooner they begin their courses of treatment. Contact your physician right away if you’re experiencing any symptoms after receiving a shot of NECC-made drugs. And make sure that your exposure gets reported to the FDA. Call us toll free at 877-307-9500 or reach our Texas drug injury lawyers online through our “Get Help Now” form.
The NECC Compounding Pharmacy knew of Contamination in its Facility and Chose not to Act to Clean It
The FDA says that even when the mold, fungus, and bacterial contamination at the NECC in Framingham, MA exceeded the company’s own safety levels, there’s no indication that the pharmacy’s staffers investigated or corrected the problems. NECC records reveal four-dozen reports of potential contamination at the pharmacy dating back just to January of this year: not even a full 12 months. These NECC reports came to light in the FDA investigation.
Continued in Part 2.